Webb A M, Russell J, Elstein M
Department of Obstetrics and Gynaecology, University of Manchester.
BMJ. 1992 Oct 17;305(6859):927-31. doi: 10.1136/bmj.305.6859.927.
To compare the effectiveness and acceptability of three regimens of postcoital contraception.
Randomised group comparison of ethinyloestradiol 100 micrograms plus levonorgestrel 500 micrograms repeated after 12 hours (Yuzpe method); danazol 600 mg repeated after 12 hours; and mifepristone 600 mg single dose.
Community family planning clinic.
616 consecutive women with regular cycles aged 16 to 45 years.
Number of pregnancies, incidence of side effects, and timing of next period.
The raw pregnancy rates (with 95% confidence intervals) for the Yuzpe, danazol, and mifepristone groups were 2.62% (0.86% to 6.00%), 4.66% (2.15% to 8.67%), and 0% (0% to 1.87%) respectively. Overall, these rates differed significantly (chi 2 = 8.988, df = 2; p = 0.011). The differences between the mifepristone and Yuzpe groups and between the mifepristone and danazol groups were also significant. Side effects were more common and more severe in the Yuzpe group (133 women (70%)) than in either the danazol group (58 (30%)) or the mifepristone group (72 (37%)). The Yuzpe regimen tended to induce bleeding early but mifepristone prolonged the cycle. Three women bled more than seven days late in the Yuzpe group compared with 49 in the mifepristone group.
Mifepristone was effective in reducing expected pregnancy rates and the Yuzpe method also had a clinical effect. Danazol had little or no effect. A further multicentre trial is needed.
比较三种性交后避孕方案的有效性和可接受性。
对炔雌醇100微克加左炔诺孕酮500微克并在12小时后重复用药(尤兹佩法)、达那唑600毫克并在12小时后重复用药、米非司酮600毫克单剂量进行随机分组比较。
社区计划生育诊所。
616名年龄在16至45岁、月经周期规律的连续就诊女性。
妊娠数、副作用发生率及下次月经时间。
尤兹佩法组、达那唑组和米非司酮组的原始妊娠率(95%置信区间)分别为2.62%(0.86%至6.00%)、4.66%(2.15%至8.67%)和0%(0%至1.87%)。总体而言,这些比率差异显著(χ² = 8.988,自由度 = 2;p = 0.011)。米非司酮组与尤兹佩法组之间以及米非司酮组与达那唑组之间的差异也显著。尤兹佩法组的副作用比达那唑组(58例(30%))或米非司酮组(72例(37%))更常见且更严重(133名女性(70%))。尤兹佩法方案倾向于使出血提前,但米非司酮会延长周期。尤兹佩法组有3名女性月经推迟超过7天,而米非司酮组有49名。
米非司酮在降低预期妊娠率方面有效,尤兹佩法也有临床效果。达那唑几乎没有效果。需要进一步进行多中心试验。